Data-driven Phenotyping Algorithms for Acute Health Conditions: Applying PheNorm to COVID-19 Read more about Data-driven Phenotyping Algorithms for Acute Health Conditions: Applying PheNorm to COVID-19
Process Guide for Inferential Studies Using Healthcare Data from Routine Clinical Practice to Evaluate Causal Effects of Drugs (PRINCIPLED): Considerations from the FDA Sentinel Innovation Center Read more about Process Guide for Inferential Studies Using Healthcare Data from Routine Clinical Practice to Evaluate Causal Effects of Drugs (PRINCIPLED): Considerations from the FDA Sentinel Innovation Center
Olumiant (Baricitinib) and Actemra (Tocilizumab) & Emergency Use Authorization (EUA) Utilization Read more about Olumiant (baricitinib) and Actemra (tocilizumab)
Pre-Pen Plus (Benzylpenicilloyl Polylysine) & Skin Test Antigen Utilization Read more about Pre-Pen Plus (benzylpenicilloyl polylysine)
Outcome Monitoring Following Dupilumab Use: A Signal Identification Analysis Read more about Outcome Monitoring Following Dupilumab Use: A Signal Identification Analysis
Empirical Application of the Sentinel EHR and Claims Data Partner Network to Enhance ARIA Sufficient Inferential Requests and Atypical Descriptive Requests (Use Case Package 2) Read more about Empirical Application of the Sentinel EHR and Claims Data Partner Network to Enhance ARIA Sufficient Inferential Requests and Atypical Descriptive Requests (Use Case Package 2)
Risk of Arterial and Venous Thrombotic Events Among Patients with COVID-19: A Multi-National Collaboration of Regulatory Agencies from Canada, Europe, and United States Read more about Risk of Arterial and Venous Thrombotic Events Among Patients with COVID-19: A Multi-National Collaboration of Regulatory Agencies from Canada, Europe, and United States